We are live on
!
Find out more
NI
Noked Israel Portfolio holdings
AUM
$677M
1-Year Est. Return
69.37%
This Fund
S&P 500
This Quarter
Est. Return
-14.26%
1 Year Est. Return
+69.37%
3 Year Est. Return
+201.74%
5 Year Est. Return
+303.34%
10 Year Est. Return
–
AUM
$119M
AUM Growth
–
Cap. Flow
+$135M
Cap. Flow
% of AUM
112.79%
Top 10 Holdings %
Top 10 Hldgs %
74.79%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$29.5M |
| 2 |
Ituran Location and Control
ITRN
|
+$15.7M |
| 3 |
Caesarstone
CSTE
|
+$12.8M |
| 4 |
SolarEdge
SEDG
|
+$9.2M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$8.26M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.1% |
| 2 | Healthcare | 25.26% |
| 3 | Industrials | 12.43% |
| 4 | Energy | 6.89% |
| 5 | Financials | 5.39% |
Similar funds
AVM
JC
MMPW
TWM
REAM
MCO
BFA
AP
Noked Israel's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Noked Israel, which disclosed 57 positions worth $119M. Its ten largest holdings account for 75% of the portfolio.
Its largest position is Teva Pharmaceuticals: 1,439,275 shares worth $22.2M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, followed by Healthcare and Industrials.
- Noked Israel's largest Q4 2018 buy was Teva Pharmaceuticals: 1,439,275 shares worth $22.2M.
- Noked Israel's ten largest holdings make up 75% of its $119M portfolio in Q4 2018.
- Noked Israel disclosed 57 positions in Q4 2018, its first 13F filing on record.
Based on Noked Israel's 13F filing for Q4 2018, filed 13 Feb 2019.